CIWA-Ar
Measures alcohol withdrawal severity in 10 items and guides symptom-triggered benzodiazepine use and level of care.
Calculate with transparency
Check the population, units and version. The result shows the formula or classification; it does not make an automatic treatment decision.
Preparing the form…
- Check the method
- Enter the data
- Check the result
Method · Limits of application
CIWA-Ar/Sullivan 1989: 10 items, total 0–67; orientation 0–4
The 1989 CIWA-Ar quantifies alcohol withdrawal severity using 10 items. Availability of the total does not establish a benzodiazepine indication or dose, level of care, or applicability to patients who cannot be adequately assessed. These elements require the clinical protocol and population for the version used.
Conditions of use
Check the population, units, inclusion and exclusion criteria, and version in the original source. A result alone does not establish a diagnosis, discharge decision or prescription.
Documented parameters
- Nausea and vomiting
- Tremor (arms extended and fingers spread)
- Paroxysmal sweating
- Anxiety
- Agitation
- Tactile disturbances (itching, tingling, burning, sensation of insects on the skin)
- Auditory disturbances (sounds louder or harsher, hearing things that are not there)
- Visual disturbances (brighter light, different colors, seeing things that are not there)
- Headache or fullness in the head
- Orientation and sensorium
4/4 reference cases checked. Numerical tests are not clinical validation.
Relationship with cancer research
General context — relationship to be defined
A resource for general clinical contexts. This edition does not assign a specific oncological relationship; selecting it for a study requires a justified question, population and purpose.